You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Last Updated: December 1, 2023

CLINICAL TRIALS PROFILE FOR MYCOBUTIN

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Mycobutin

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00002343 ↗	A Study of Rifabutin, Used Alone or With Ethambutol in the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in Patients With AIDS	Completed	Pharmacia	Phase 4	1969-12-31	To optimize Mycobacterium avium Complex (MAC) prophylaxis in AIDS patients by measuring serum rifabutin levels and adjusting the dose accordingly. To combine rifabutin with ethambutol to examine the effect of combination therapy in preventing or delaying the incidence of MAC bacteremia in this patient population.
NCT00598897 ↗	Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC) Lung Disease	Completed	Abbott	Phase 4	1995-08-01	To determine the safety and tolerance of clarithromycin given three times per week in combination with multiple drugs including rifabutin three times per week
NCT00598897 ↗	Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC) Lung Disease	Completed	Pfizer	Phase 4	1995-08-01	To determine the safety and tolerance of clarithromycin given three times per week in combination with multiple drugs including rifabutin three times per week
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Mycobutin

Condition Name

Chart
Table

Condition Name for Mycobutin
Intervention	Trials
Tuberculosis	3
Non-tuberculous Mycobacterial Diseases (Including MAC Disease)	2
HIV Infections	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Mycobutin
Intervention	Trials
Mycobacterium Infections	5
HIV Infections	4
Mycobacterium avium-intracellulare Infection	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Mycobutin

Trials by Country

Map
Table

Trials by Country for Mycobutin
Location	Trials
United States	3
South Africa	1
Italy	1
Australia	1
Uganda	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Mycobutin
Location	Trials
Texas	2
California	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Mycobutin

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Mycobutin
Clinical Trial Phase	Trials
Phase 4	4
Phase 3	1
Phase 2	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Mycobutin
Clinical Trial Phase	Trials
Completed	7
Unknown status	2
Terminated	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Mycobutin

Sponsor Name

Chart
Table

Sponsor Name for Mycobutin
Sponsor	Trials
Pfizer	4
Boehringer Ingelheim	2
Abbott	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Mycobutin
Sponsor	Trials
Industry	9
Other	7
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca

Baxter

Harvard Business School

Dow

Express Scripts

Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.